published patent: Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke

TitleProphylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke
Priority Date2006-02-20 JP20060041761
2007-02-20 PCT/JP2007053036
Inventors
Issue Date2007
Citation
Australia Published Patent Application AU 2007218709. Australia: IP Australia, 2007 How to Cite?
AbstractThe present invention provides a preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemic reperfusion injury in stroke such as cerebral infarction and cerebral hemorrhage which exerts its effect through a different mechanism from that of conventional therapeutic agents and can be taken for a long period. The present invention is a preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemic reperfusion injury in stroke which contains 6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide as an active ingredient. A particularly preferable compound is an optically resolved (2S,4S)-form of fidarestat.
Persistent Identifierhttp://hdl.handle.net/10722/176546

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:06Z-
dc.date.available2012-11-30T08:38:06Z-
dc.date.issued2007-
dc.identifier.citationAustralia Published Patent Application AU 2007218709. Australia: IP Australia, 2007en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176546-
dc.description.abstractThe present invention provides a preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemic reperfusion injury in stroke such as cerebral infarction and cerebral hemorrhage which exerts its effect through a different mechanism from that of conventional therapeutic agents and can be taken for a long period. The present invention is a preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemic reperfusion injury in stroke which contains 6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide as an active ingredient. A particularly preferable compound is an optically resolved (2S,4S)-form of fidarestat.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleProphylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in strokeen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorChung, SKen_HK
dc.contributor.inventorStephen Chungen_HK
dc.contributor.inventorChihiro Hibien_HK
patents.identifier.applicationAU 20070218709en_HK
patents.description.assigneeSANWA KAGAKU KENKYUSHO COen_HK
patents.description.countryAustraliaen_HK
patents.date.publication2007-08-30en_HK
patents.date.application2007-02-20en_HK
patents.date.priority2006-02-20 JP20060041761en_HK
patents.date.priority2007-02-20 PCT/JP2007053036en_HK
patents.description.ccAUen_HK
patents.identifier.publicationAU 2007218709en_HK
patents.relation.familyAU 2007218709 (A1) 2007-08-30en_HK
patents.relation.familyCA 2642933 (A1) 2007-08-30en_HK
patents.relation.familyCN 101389332 (A) 2009-03-18en_HK
patents.relation.familyEP 1987829 (A1) 2008-11-05en_HK
patents.relation.familyKR 20080108465 (A) 2008-12-15en_HK
patents.relation.familyUS 2009076105 (A1) 2009-03-19en_HK
patents.relation.familyWO 2007097301 (A1) 2007-08-30en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats